Oculis Holding AG (OCS) Prepaid Assets (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Prepaid Assets of $4.9 million in Q1 2026, down 20.55% quarter-over-quarter from $6.1 million in Q4 2025, and down 26.42% on a YoY basis from $6.6 million in Q1 2025.
Oculis Holding AG (OCS) Prepaid Assets (2021 - 2026) Analysis & Trends
Oculis Holding AG's Prepaid Assets history runs 6 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 26.42% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 26.42% YoY), while the FY2025 annual figure was $6.1 million, down 4.51% from the prior year.
- Prepaid Assets was $4.9 million for Q1 2026 at Oculis Holding AG, down from $6.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.6 million in Q4 2023 to a low of $3.1 million in Q4 2022.
- Historically, Prepaid Assets has averaged $6.1 million across 5 years, with a median of $5.9 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 2279.98% in 2022, then sank 37.65% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $3.1 million in 2022, then surged by 211.54% to $9.6 million in 2023, then sank by 33.14% to $6.4 million in 2024, then slipped by 4.51% to $6.1 million in 2025, then declined by 20.55% to $4.9 million in 2026.
- The last three Prepaid Assets figures came in at $4.9 million (Q1 2026), $6.1 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.85 Mn |
| Dec 31, 2025 | 6.11 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 6.40 Mn |
| Sep 30, 2024 | 5.14 Mn |
| Jun 30, 2024 | 5.89 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 9.57 Mn |
| Sep 30, 2023 | 8.24 Mn |
| Jun 30, 2023 | 6.74 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Dec 31, 2021 | 129,055.75 |